The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression
Open Access
- 15 May 2001
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 84 (10), 1372-1376
- https://doi.org/10.1054/bjoc.2001.1791
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.1999
- The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53Cell, 1998
- ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression PathwaysCell, 1998
- Stage-Specific Expression of Polycomb Group Genes in Human Bone Marrow CellsBlood, 1998
- Functional analysis of mouse Polycomb group genesCellular and Molecular Life Sciences, 1998
- G1 control gene status is frequently altered in resectable non-small cell lung cancerInternational Journal of Cancer, 1997
- Perturbation of B and T cell development and predisposition to lymphomagenesis in EμBmi1 transgenic mice require the Bmi1 RING fingerOncogene, 1997
- Functions of mammalian Polycomb group and trithorax group related genesCurrent Opinion in Genetics & Development, 1997
- Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian polycomb complex.Genes & Development, 1997
- Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancerBritish Journal of Cancer, 1996